Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.

The Journal of antimicrobial chemotherapy - 1 Mar 2007

Booth Clare L, Garcia-Diaz Ana M, Youle Michael S, Johnson Margaret A, Phillips Andrew, Geretti Anna Maria

Abstract excerpt

OBJECTIVES: To determine prevalence and predictors of antiretroviral drug resistance in newly diagnosed individuals with HIV-1 infection, using a systematic approach to avoid selection bias. METHODS: Plasma samples from all persons diagnosed HIV-1 seropositive at a large London centre between April 2004 and February 2006 underwent sequencing of HIV-1 reverse transcriptase (RT) and protease genes. Subtype was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acquired Immunodeficiency Syndrome
Share to Anti-HIV Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Viral

Share to HIV Antibodies

Share to Prevalence

Source

Identifiers

PMID: 17213262
DOI: 10.1093/jac/dkl501

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection.PMID 17213262Read ↗

HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom.Semantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom.Semantic proximity Read ↗

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational studySemantic proximity Read ↗

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.Semantic proximity Read ↗

Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.Semantic proximity Read ↗

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.Semantic proximity Read ↗

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infection.Semantic proximity Read ↗

Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis.Semantic proximity Read ↗

HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey.Semantic proximity Read ↗

Limited transmission of drug-resistant HIV type 1 in 100 Swedish newly detected and drug-naive patients infected with subtypes A, B, C, D, G, U, and CRF01_AE.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.